Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

This is an early-phase study testing a new investigational drug called CP-383 in people with advanced or metastatic solid tumors (cancers that have spread and are no longer responding to standard treatments). **You may be eligible if:** - You have an advanced, recurrent, or metastatic solid tumor (not brain cancer) - Standard treatments are no longer working, are not available, or are not tolerable for you - You have measurable or detectable cancer on imaging - Tumor tissue is available for testing, or you are willing to have a biopsy - You are in good physical health and can carry out daily activities **You may NOT be eligible if:** - You have primary brain cancer (other solid tumors with brain metastases may be considered) - You have a serious active infection, autoimmune disease, or significant organ damage - You are pregnant or breastfeeding - You have received certain prior treatments that would interfere with this drug Talk to your doctor to see if this trial is right for you.